https://www.selleckchem.com/products/OSI027.html 41, P=1.4×10 ), estimated glomerular filtration rate (β=0.28, P=6.0×10 ), *** (β=0.28, P=5.7×10 ) and SLC5A2 rs9934336 polymorphism (β=0.17, P=0.02) were significantly correlated with urinary glucose excretion. The frequency of the A allele of rs9934336 tended to be lower in participants with type2 diabetes than in controls (odds ratio 0.78, 95% confidence interval 0.53-1.13, not significant), and meta-analysis showed a significant association between the A allele and type2 diabetes (summary odds ratio for minor allele [A] 0.86, 95% confidence interval 0.78-0.94, P<0.002). Blood glucose, estimated glomerular filtration rate, *** and SLC5A2 polymorphism were independent determinants of glucosuria in diabetes mellitus. Blood glucose, estimated glomerular filtration rate, *** and SLC5A2 polymorphism were independent determinants of glucosuria in diabetes mellitus. To analyze the use of the Multidimensional Health Assessment Questionnaire (MDHAQ) to screen for depression, as compared to 2 reference standards, the Patient Health Questionnaire 9 (PHQ-9) and the Hospital Anxiety and Depression Scale depression domain (HADS-D). Patients from Barcelona with a primary diagnosis of rheumatoid arthritis (RA) or spondyloarthritis (SpA) completed the MDHAQ, the PHQ-9 (depression ≥10), and the HADS-D (depression ≥8) measures. The MDHAQ includes 2 depression items, 1 in the patient-friendly HAQ, scored in a 4-point format from 0 to 3.3, and a yes/no item on a 60-symptom checklist. Percentage agreement and kappa statistics quantified the agreement between 6 screening criteria yes on the 60-symptom checklist, a score of ≥1.1, a score of ≥2.2 on a 4-point scale, and either a response of yes on the 60-symptom checklist or scores of ≥2.2, PHQ-9 ≥10, and HADS-D ≥8. Depression screening was positive according to 6 criteria in 19.6-32.4% of 102 patients with RA, and 27.9-44.8% of 68 n a 60-symptom checklist or a score of ≥2.2 on a 4-point sc